Yourgene Health Plc announced the appointment of Joanne Mason as Chief Scientific Officer as a director of the Company with immediate effect. Mason has been director of Research & Development (non-board position) at Yourgene since joining the Company in December 2019, leading the development of next generation molecular diagnostics, particularly in the area of reproductive health. She has previously acted as an advisor on the Department of Health (DOH) Rare Disease Policy Board and Forum the Medicines and Healthcare products Regulatory Agency (MHRA) Genomics for Diagnosis Forum and the UK National External Quality Assessment (NEQAS) - Genomics England Steering Committee, Genomics England Sequencing Advisory Board and Bioindustry Association (BIA) Genomics Advisory Committee. Bill Chang, continues on the Board as a director, in a new role as Chief Entrepreneur focusing on new scientific collaborations and business ventures for the Group, and remains a significant shareholder.